Neoantigen Targeting T Cells (Genoimmune Therapeutics)

N/A

Report date: 2024/11/26 16:13:30

Base Information

Drug NameNeoantigen Targeting T Cells (Genoimmune Therapeutics)
Drug Alias NameNeo-T (Genoimmune Therapeutics)Neoantigen-targeting autologous T-cell therapy (Genoimmune Therapeutics)Neoantigen Targeting T Cells Suspension for Intravenous Infusion (Genoimmune Therapeutics)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionHuman leukocyte antigen modulators
TargetsHuman leukocyte antigen
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGenoimmune Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesBgi China No 1 Investment Enterprise Partnership Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A